Mechanism of salvianolic phenolic acids and hawthorn triterpenic acids combination in intervening atherosclerosis: network pharmacology, molecular docking, and experimental validation

被引:0
|
作者
Zhai, Qu [1 ]
Shang, Shixi [2 ]
Zhang, Zihan [3 ]
Sun, Lihua [2 ]
Huang, Ying [2 ]
Feng, Shuyi [2 ]
Wu, Qian [2 ]
Cui, Haifeng [2 ]
Shi, Xiaolu [2 ]
机构
[1] China Natl Med Prod Adm, Inst Execut Dev, Beijing, Peoples R China
[2] China Acad Chinese Med Sci, Expt Res Ctr, Beijing Key Lab TCM Basic Res Prevent & Treatment, Beijing, Peoples R China
[3] Beijing Univ Chinese Med, Beijing, Peoples R China
关键词
salvianolic phenolic acids; hawthorn triterpenic acids; atherosclerosis; network pharmacology; molecular docking; inflammatory regulatory; CELLS; ANTIOXIDANT; ACTIVATION; EXPRESSION; APOPTOSIS; STATINS; DANSHEN;
D O I
10.3389/fphar.2025.1501846
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background This study employs network pharmacology and molecular docking methods in conjunction with animal experimentation to elucidate the underlying mechanism by which the combination of salvianolic phenolic acids and hawthorn triterpenic acids (SHC) exerts its therapeutic effect on carotid atherosclerosis (AS) in ApoE-/- mice.Methods A network pharmacology research approach was used to predict potential core targets for SHC intervention in atherosclerosis. The predictions were subsequently validated through the implementation of animal in vivo experiments. ApoE-/- mice were randomly assigned to three experimental groups, namely, a model group, an atorvastatin group, and an SHC group. After the administration period, the plaque area in the carotid artery and aortic arch, blood lipid levels, malondialdehyde (MDA), superoxide dismutase (SOD), glutathione (GSH), and nitric oxide (NO) content were measured. Additionally, the expression of PI3K, Akt, NF-kappa B, JNK1, ERK1/2, and p38-MAPK in the aortic arteries was analyzed. Based on the protein expression results, molecular docking was used to predict the binding activity between the core compounds and core targets.Results A total of 23 core compounds were identified in SHC, and 55 core targets of SHC were screened as potential targets for intervention in AS. The results of the enrichment analysis indicated that the principal mechanisms through which SHC exerts its effects in AS are associated with lipid metabolism and the PI3K-Akt and MAPK pathways. The results from animal experiments demonstrated that atorvastatin and SHC markedly reduced the area of carotid plaque and downregulated the levels of TC and LDL-C in ApoE-/- mice. The administration of SHC was associated with an increase in SOD activity and a reduction in NO levels in the livers of mice. Furthermore, SHC was observed to downregulate the expression of NF-kappa B and p38-MAPK in the carotid region. The results of molecular docking demonstrated that the core compounds of SHC, including salvianolic acid A, B, and C, maslinic acid, ursolic acid, and oleic acid, were capable of stably binding to the core targets NF-kappa B and MAPK14.Conclusion It is hypothesized that SHC may reduce lipid deposition and plaque formation in AS by regulating blood lipids, a process that may be closely linked to the inhibition of inflammatory regulator expression, including NF-kappa B and p38-MAPK.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Mechanism of ethyl acetate fraction of Amorphophallus konjac against breast cancer based on network pharmacology, molecular docking and experimental validation
    Mei, Huimin
    Yang, Jinglong
    Hao, Jiapeng
    Ding, Yushan
    Wan, Xinliang
    Dong, Minghong
    Zhang, Xudong
    Luo, Liying
    Xiong, Tongtong
    Wang, Lu
    Yang, Tianming
    Huang, Cong
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 345
  • [22] Mechanism of Simiao Decoction in the treatment of atherosclerosis based on network pharmacology prediction and molecular docking
    Li, Qian
    Chai, Yihui
    Li, Wen
    Guan, Liancheng
    Fan, Yizi
    Chen, Yunzhi
    MEDICINE, 2023, 102 (36) : E35109
  • [23] Effects and mechanisms of Zhizi Chuanxiong herb pair against atherosclerosis: an integration of network pharmacology, molecular docking, and experimental validation
    Yan Zhang
    Yifei Qi
    Zijun Jia
    Yiming Li
    Liqi Wu
    Qingbing Zhou
    Fengqin Xu
    Chinese Medicine, 19
  • [24] Investigation of the mechanism of baicalein in the treatment of periodontitis based on network pharmacology, molecular docking and experimental validation
    Liu, Yue
    Cao, Fengdi
    Shi, Mingyue
    Deng, Zhuohang
    Guo, Kaili
    Fan, Tiantian
    Meng, Yuhan
    Bu, Mingyang
    Ma, Zhe
    BMC ORAL HEALTH, 2024, 24 (01):
  • [25] Integrating network pharmacology, molecular docking, and experimental validation to reveal the mechanism of Radix Rehmanniae in psoriasis
    Mo, Nian
    Zhou, Panyu
    Liu, Fanlu
    Su, Haojie
    Han, Ling
    Lu, Chuanjian
    MEDICINE, 2024, 103 (43) : e40211
  • [26] Mechanism of Curcumin in the Treatment of Intrauterine Adhesions Based on Network Pharmacology, Molecular docking, and Experimental Validation
    Li, Qiaoxia
    Zhang, Yongyan
    Shen, Haoyu
    Wang, Ziqian
    Huang, Jiezhuang
    Tang, Shuli
    Chen, Peiyue
    Zhi, Zhifu
    BIOCHEMICAL GENETICS, 2025,
  • [27] Mechanisms of action of Sappan lignum for prostate cancer treatment: network pharmacology, molecular docking and experimental validation
    Li, Wenna
    Jiang, Honglin
    Zhang, Weina
    Sun, Qiuyue
    Zhang, Qiaoli
    Xu, Jingnan
    Huang, Jinchang
    Wan, Yuxiang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] The Molecular Mechanism of Resveratrol in the Treatment of Chronic Rhinosinusitis Through a Combination of Network Pharmacology and In Vitro Validation
    Cheng, Xiao
    Xu, Shanshan
    Han, Furong
    Song, Zhihui
    Wang, Jiawei
    CHEMICAL BIOLOGY & DRUG DESIGN, 2025, 105 (03)
  • [29] Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis
    Liang, Jiahua
    Huang, Yingjie
    Mai, Zhexing
    Zhan, Qunzhang
    Lin, Hengchen
    Xie, Yuxin
    Wang, Haihao
    Liu, Yan
    Luo, Chuanjin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 1779 - 1795
  • [30] Integrated Serum Pharmacochemistry, Network Pharmacology, and Molecular Docking to Study the Mechanism of Rhubarb against Atherosclerosis
    Cai, Zhi-Yan
    Li, Shu-Jiao
    Wang, Yu-Qing
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2025, 26 (04) : 564 - 575